Ebola virus epidemic in West Africa (2014–2016)

Ebola virus epidemic in West Africa (2014–2016)
Name	Ebola virus epidemic in West Africa (2014–2016)
Disease	Ebola virus disease
Virus strain	Zaire ebolavirus
Outbreak period	December 2013 – June 2016
Locations	Guinea; Liberia; Sierra Leone; Nigeria; Senegal; Mali; United States; Spain; United Kingdom; Italy; Germany; France
Deaths	~11,300
Confirmed cases	~28,600

Ebola virus epidemic in West Africa (2014–2016) The Ebola virus epidemic in West Africa (2014–2016) was the largest and most complex outbreak of Ebola virus disease since the virus was discovered, affecting multiple nations and eliciting responses from global institutions. The epidemic began in southeastern Guinea and spread rapidly to Liberia and Sierra Leone, prompting interventions by the World Health Organization, Médecins Sans Frontières, Centers for Disease Control and Prevention, and national governments across Africa and beyond.

Background

The epidemic originated in Meliandou, a village in the Nzérékoré Region of Guinea, in December 2013, with early cases linked to human contact with wildlife in the Guinea Highlands and the Nimba Range. Prior Ebola outbreaks had occurred in Zaire (now Democratic Republic of the Congo), Sudan and Gabon; the 1976 discovery of Ebolavirus followed investigations by teams associated with the Centers for Disease Control and Prevention and the World Health Organization. The agent responsible for the West African epidemic was identified as Zaire ebolavirus, genetically related to strains sampled during outbreaks near the Congo River and in Gabon. Political instability in Guinea-Bissau and porous borders with Liberia and Sierra Leone facilitated cross-border movement, complicating surveillance by national ministries such as the Ministry of Health and Social Action (Guinea).

Outbreak progression and timeline

Initial transmission in Meliandou spread to nearby towns and the regional capital Guéckédou before cases appeared in the capital city, Conakry, and in Kerouane. In March 2014, national authorities in Guinea notified the World Health Organization. By May 2014 the epidemic had reached Monrovia (capital of Liberia) and Freetown (capital of Sierra Leone), with urban transmission amplifying case counts. In July 2014 the WHO declared a Public Health Emergency of International Concern; subsequent international events included emergency missions by Médecins Sans Frontières, the deployment of personnel from the United Kingdom and United States Department of Defense, and laboratory support from the Bernhard Nocht Institute for Tropical Medicine and the Pasteur Institute. Notable exported cases included patients treated in Madrid (Spain), Dallas (United States), Rome (Italy), and Paris (France). By early 2015, with intensified control efforts in Liberia and Sierra Leone, transmission declined; in June 2016 the WHO declared the outbreak over following the last chain of transmission in Guinea.

Epidemiology and transmission

Transmission occurred primarily through direct contact with bodily fluids from symptomatic patients and corpses during traditional burial rites in regions such as Kailahun District and Lofa County, with nosocomial amplification in facilities like Ebola treatment centers run by International Red Cross and Red Crescent Movement. Superspreading events were documented in settings including hospitals linked to Connaught Hospital (Freetown) and community gatherings in Kambia District. Surveillance and case definitions were coordinated with guidance from the World Health Organization, and molecular epidemiology used sequencing at centers like the European Molecular Biology Laboratory to map transmission chains. Vulnerable populations included healthcare workers in institutions such as John F. Kennedy Medical Center and populations displaced by regional instability near Sierra Leone-Liberia border. Reproductive number estimates informed interventions recommended by the Centers for Disease Control and Prevention and modeling groups at Imperial College London.

Response and containment efforts

Responses combined clinical care, infection prevention and control, surveillance, and social mobilization led by actors including Médecins Sans Frontières, the World Health Organization, the United Nations Mission for Ebola Emergency Response, and national ministries such as the Ministry of Health and Social Welfare (Liberia). Field laboratories were established with support from the United States Agency for International Development, the UK Department for International Development, and the European Commission. Military assets from the United States Africa Command and the British Army assisted logistics and construction of treatment units; mobile laboratories and rapid diagnostic capacity were bolstered by teams from the National Institutes of Health and the Bernhard Nocht Institute for Tropical Medicine. Community engagement efforts involved collaborations with traditional leaders from regions including Kailahun District, religious authorities linked to Freetown parishes, and civil society organizations such as Sierra Leone Association of Ebola Survivors.

Impact and consequences

The epidemic caused approximately 28,600 cases and 11,300 deaths, with catastrophic effects on health systems in Guinea, Liberia, and Sierra Leone, reducing routine services at facilities like Connaught Hospital and increasing mortality from malaria and maternal conditions tracked by UNICEF and the World Bank. Economies suffered severe contractions monitored by the International Monetary Fund and the World Bank Group, while social disruption included school closures enforced by ministries in Freetown and Monrovia, and displacement affecting camps near Kakata and Kailahun District. International travel restrictions and border controls were instituted by states such as Mali and Senegal, and legal measures were debated in parliamentary bodies like the National Assembly (Liberia). Stigma against survivors led to programs run by United Nations Development Programme and International Rescue Committee to support reintegration. The epidemic also influenced global health policy, prompting reviews by the Global Health Security Agenda and the G7.

Scientific research and treatments

Scientific efforts accelerated vaccine and therapeutic development through collaborations involving the National Institutes of Health, GlaxoSmithKline, Merck & Co., and research institutions such as the London School of Hygiene & Tropical Medicine and the Institut Pasteur. The rVSV-ZEBOV vaccine underwent ring vaccination trials coordinated with the World Health Organization and the Norwegian Institute of Public Health in Guinea, while therapeutics including monoclonal antibodies developed by teams at Public Health Agency of Canada and antiviral candidates evaluated in protocols approved by ethics committees at institutions including Harvard T.H. Chan School of Public Health. Clinical data from treatment centers like those run by Médecins Sans Frontières and investigational trials overseen by the NIH informed later licensure decisions. Survivorship studies conducted by groups at Johns Hopkins University and the London School of Hygiene & Tropical Medicine documented post-Ebola sequelae and viral persistence in immune-privileged sites.

International coordination and lessons learned

The epidemic revealed weaknesses in global preparedness and spurred reforms within the World Health Organization, including changes debated at World Health Assembly sessions and contributions from the United Nations and the Global Outbreak Alert and Response Network. Multinational efforts involved coordination across the European Union, the African Union, and bilateral partnerships with the United States and United Kingdom. Lessons learned informed the creation of mechanisms such as the WHO Health Emergencies Programme and influenced pandemic preparedness frameworks endorsed by the G20 and the Global Health Security Agenda. The epidemic underscored the importance of integrating surveillance capacities at institutions like national public health institutes, strengthening laboratory networks including the Africa Centres for Disease Control and Prevention, and improving community engagement through partnerships with organizations such as Red Cross Society and Sierra Leone Association of Ebola Survivors.

Category:Ebola virus outbreaks Category:2014 in Sierra Leone Category:2015 in Liberia Category:2016 in Guinea